Back to Trials
NCT06331377Recruiting

Clinical and Molecular Characteristics of Histiocytic Disorders

Mayo Clinic

Start Date

7/27/2017

Completion Date

7/31/2027

Summary

This study is being done to collect medical and personal histories as well as a samples of blood, other body fluid and/or tumor/disease tissue for current and future research studies on histiocytic disorders.

Detailed Description

PRIMARY OBJECTIVES: I. Define molecular signature and genomic landscape of histiocytic disorders. II. Correlate genomic findings with transcriptional abnormalities. III. Identify promising prognostic alterations and potential therapeutic targets. OUTLINE: This is an observational study. Patients complete questionnaires and undergo blood and tissue sample collection. Patients' medical records are also reviewed.

Eligibility Criteria

Age Range: 1 years to No maximum

Inclusion Criteria: * \* All patients diagnosed with histiocytic disorders and age ≥1 year Exclusion Criteria: * \* \< 1 years age

Interventions

OTHER

Non-Interventional Study

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Histiocytic Disorder

Locations

Mayo Clinic in Rochester

Rochester, Minnesota 55905

United States